Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 307
Dvorak, V, Casiraghi, A, Colas, C, Koren, A, Tomek, T, Offensperger, F, Rukavina, A, Tin, G, Hahn, E, Dobner, S, Frommelt, F, Boeszoermenyi, A, Bernada, V, Hannich, JT, Ecker, GF, Winter, GE, Kubicek, S & Superti-Furga, G 2023, 'Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors', Cell Chemical Biology, vol. 30, no. 8, pp. 953-964.e9. https://doi.org/10.1016/j.chembiol.2023.06.029

Activities

Drug efflux pumps - From target to antitarget

Gerhard Ecker
Talk or oral contribution
15.11.2006 - 15.11.2006

MDR - Multiple Drug Resistance

Gerhard Ecker
Trends in Medicinal Chemistry
Conference, Talk or oral contribution
9.10.2006 - 9.10.2006

Pharmacoinformatic approaches to target the molecular basis of polyspecificity

Gerhard Ecker
Pharmacy meets Theoretical Chemistry
Seminar/Workshop, Talk or oral contribution
28.9.2006 - 28.9.2006

ABC-transporter as antitargets

Gerhard Ecker
3rd Summer School Medicinal Chemistry
Summer/Winter school, Talk or oral contribution
26.9.2006 - 26.9.2006

In silico methods for prediction of P-glycoprotein substrates

Gerhard Ecker
19th International Symposium on Medicinal Chemistry
Conference, Talk or oral contribution
30.8.2006 - 30.8.2006